FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213524712> ?p ?o ?g. }

• W3213524712 endingPage "26" @default.
• W3213524712 startingPage "19" @default.
• W3213524712 abstract "Triple-negative breast cancer (TNBC) is one of the most aggressive types of breast cancer with poor outcomes. Patients with TNBC cannot benefit from targeted therapies such as Tamoxifen and Herceptin. The aim of the present study was to seek a preventive or therapeutic agent with a potential inhibitory effect on aggressive progression of TNBC. Anticancer effect of a natural compound curcumin have been demonstrated, however, development of more effective curcumin analogs with better bioavailability is needed. We investigated if a curcumin analog CA-5f could inhibit the invasive phenotype of TNBC cell lines in the present study. Treatment with CA-5f inhibited the viability of MDA‑MB‑231 and Hs578T TNBC cells, possible by inducing apoptosis. The invasive phenotypes of these cells were inhibited by CA-5f in a concentration-dependent manner. Protein expression of urokinase-type plasminogen activator (uPA), a serine protease known to degrade the extracellular matrix and lead to invasion, was markedly decreased by CA-5f in Hs578T cells. However, mRNA level of uPA was not altered by CA-5f, implicating that the effect of CA-5f was not through transcriptional regulation. Of note, CA-5f upregulated plasminogen activator inhibitor type (PAI)-1, which is known to inhibit uPA by interacting with urokinase-type plasminogen receptor, in TNBC cells. Taken together, these results demonstrated that CA-5f significantly inhibited the invasive phenotype of TNBC cells, possibly by decreasing the protein level of uPA through upregulating PAI-1. Our results may provide useful information on developing CA-5f as a potential therapeutic agent against malignant progression of TNBC." @default.
• W3213524712 created "2021-11-22" @default.
• W3213524712 creator A5067898316 @default.
• W3213524712 creator A5083115378 @default.
• W3213524712 date "2021-11-17" @default.
• W3213524712 modified "2023-09-30" @default.
• W3213524712 title "A curcumin analog CA-5f inhibits urokinase-type plasminogen activator and invasive phenotype of triple-negative breast cancer cells" @default.
• W3213524712 cites W1574621194 @default.
• W3213524712 cites W1595226937 @default.
• W3213524712 cites W1949499243 @default.
• W3213524712 cites W1964552652 @default.
• W3213524712 cites W1973528397 @default.
• W3213524712 cites W1975475567 @default.
• W3213524712 cites W1981442074 @default.
• W3213524712 cites W1982397837 @default.
• W3213524712 cites W1995249913 @default.
• W3213524712 cites W1995406904 @default.
• W3213524712 cites W1999463736 @default.
• W3213524712 cites W2005020033 @default.
• W3213524712 cites W2005855604 @default.
• W3213524712 cites W2008111120 @default.
• W3213524712 cites W2013524931 @default.
• W3213524712 cites W2018235962 @default.
• W3213524712 cites W2024982137 @default.
• W3213524712 cites W2027275036 @default.
• W3213524712 cites W2029375682 @default.
• W3213524712 cites W2034061102 @default.
• W3213524712 cites W2072775893 @default.
• W3213524712 cites W2092032160 @default.
• W3213524712 cites W2093829133 @default.
• W3213524712 cites W2100056506 @default.
• W3213524712 cites W2105618564 @default.
• W3213524712 cites W2116508133 @default.
• W3213524712 cites W2133896679 @default.
• W3213524712 cites W2148081733 @default.
• W3213524712 cites W2150510390 @default.
• W3213524712 cites W2234070446 @default.
• W3213524712 cites W2313239257 @default.
• W3213524712 cites W2345605434 @default.
• W3213524712 cites W2398137309 @default.
• W3213524712 cites W2405442768 @default.
• W3213524712 cites W2474877235 @default.
• W3213524712 cites W2589937051 @default.
• W3213524712 cites W2604873860 @default.
• W3213524712 cites W2731058852 @default.
• W3213524712 cites W2747234998 @default.
• W3213524712 cites W2791482536 @default.
• W3213524712 cites W2800586937 @default.
• W3213524712 cites W2888914712 @default.
• W3213524712 cites W2971629853 @default.
• W3213524712 cites W3046137655 @default.
• W3213524712 cites W3097172820 @default.
• W3213524712 doi "https://doi.org/10.1007/s43188-021-00112-2" @default.
• W3213524712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35070937" @default.
• W3213524712 hasPublicationYear "2021" @default.
• W3213524712 type Work @default.
• W3213524712 sameAs 3213524712 @default.
• W3213524712 citedByCount "10" @default.
• W3213524712 countsByYear W32135247122022 @default.
• W3213524712 countsByYear W32135247122023 @default.
• W3213524712 crossrefType "journal-article" @default.
• W3213524712 hasAuthorship W3213524712A5067898316 @default.
• W3213524712 hasAuthorship W3213524712A5083115378 @default.
• W3213524712 hasBestOaLocation W32135247122 @default.
• W3213524712 hasConcept C121608353 @default.
• W3213524712 hasConcept C126322002 @default.
• W3213524712 hasConcept C134018914 @default.
• W3213524712 hasConcept C185592680 @default.
• W3213524712 hasConcept C2776892390 @default.
• W3213524712 hasConcept C2778250585 @default.
• W3213524712 hasConcept C2779679481 @default.
• W3213524712 hasConcept C2780110267 @default.
• W3213524712 hasConcept C2780675426 @default.
• W3213524712 hasConcept C502942594 @default.
• W3213524712 hasConcept C530470458 @default.
• W3213524712 hasConcept C55493867 @default.
• W3213524712 hasConcept C56219504 @default.
• W3213524712 hasConcept C71924100 @default.
• W3213524712 hasConcept C86803240 @default.
• W3213524712 hasConcept C96232424 @default.
• W3213524712 hasConceptScore W3213524712C121608353 @default.
• W3213524712 hasConceptScore W3213524712C126322002 @default.
• W3213524712 hasConceptScore W3213524712C134018914 @default.
• W3213524712 hasConceptScore W3213524712C185592680 @default.
• W3213524712 hasConceptScore W3213524712C2776892390 @default.
• W3213524712 hasConceptScore W3213524712C2778250585 @default.
• W3213524712 hasConceptScore W3213524712C2779679481 @default.
• W3213524712 hasConceptScore W3213524712C2780110267 @default.
• W3213524712 hasConceptScore W3213524712C2780675426 @default.
• W3213524712 hasConceptScore W3213524712C502942594 @default.
• W3213524712 hasConceptScore W3213524712C530470458 @default.
• W3213524712 hasConceptScore W3213524712C55493867 @default.
• W3213524712 hasConceptScore W3213524712C56219504 @default.
• W3213524712 hasConceptScore W3213524712C71924100 @default.
• W3213524712 hasConceptScore W3213524712C86803240 @default.
• W3213524712 hasConceptScore W3213524712C96232424 @default.
• W3213524712 hasFunder F4320321217 @default.
• W3213524712 hasIssue "1" @default.

• next